DK101982A - Fremgangsmaade til fremstilling af en vaccine til hindring af gastroenterisk sygdom fremkaldt i et pattedyr af en patogen mikroorganisme - Google Patents

Fremgangsmaade til fremstilling af en vaccine til hindring af gastroenterisk sygdom fremkaldt i et pattedyr af en patogen mikroorganisme Download PDF

Info

Publication number
DK101982A
DK101982A DK101982A DK101982A DK101982A DK 101982 A DK101982 A DK 101982A DK 101982 A DK101982 A DK 101982A DK 101982 A DK101982 A DK 101982A DK 101982 A DK101982 A DK 101982A
Authority
DK
Denmark
Prior art keywords
genes
pathogenic microorganism
vaccine
prevention
mammal
Prior art date
Application number
DK101982A
Other languages
English (en)
Other versions
DK172670B1 (da
Inventor
W S Dallas
Original Assignee
Cetus Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cetus Corp filed Critical Cetus Corp
Publication of DK101982A publication Critical patent/DK101982A/da
Application granted granted Critical
Publication of DK172670B1 publication Critical patent/DK172670B1/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/02Bacterial antigens
    • A61K39/025Enterobacteriales, e.g. Enterobacter
    • A61K39/0258Escherichia
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/24Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
    • C07K14/245Escherichia (G)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/67General methods for enhancing the expression
    • C12N15/68Stabilisation of the vector
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/51Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/523Bacterial cells; Fungal cells; Protozoal cells expressing foreign proteins
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Plant Pathology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Mycology (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
DK198201019A 1981-03-09 1982-03-09 Fremgangsmåde til fremstilling af en vaccine til hindring af gastroenterisk sygdom fremkaldt i et pattedyr af en patogen mi DK172670B1 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US24159481A 1981-03-09 1981-03-09
US24159481 1981-03-09

Publications (2)

Publication Number Publication Date
DK101982A true DK101982A (da) 1982-09-10
DK172670B1 DK172670B1 (da) 1999-05-10

Family

ID=22911341

Family Applications (1)

Application Number Title Priority Date Filing Date
DK198201019A DK172670B1 (da) 1981-03-09 1982-03-09 Fremgangsmåde til fremstilling af en vaccine til hindring af gastroenterisk sygdom fremkaldt i et pattedyr af en patogen mi

Country Status (9)

Country Link
EP (1) EP0060129B1 (da)
JP (1) JP2554611B2 (da)
AT (1) ATE47961T1 (da)
AU (1) AU559550B2 (da)
CA (1) CA1201076A (da)
DE (1) DE3280019D1 (da)
DK (1) DK172670B1 (da)
NZ (1) NZ199866A (da)
WO (1) WO1982003088A1 (da)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5137721A (en) * 1981-03-09 1992-08-11 Cetus Corporation Employing strains of E. coli expressing non-indigenous adhesins and toxoids of E. coli
US5360897A (en) * 1981-08-31 1994-11-01 The University Of Rochester Immunogenic conjugates of streptococcus pneumonial capsular polymer and toxin or in toxiad
US5097020A (en) * 1983-07-05 1992-03-17 The University Of Rochester Immunogenic conjugates
US4673574A (en) * 1981-08-31 1987-06-16 Anderson Porter W Immunogenic conjugates
US4902506A (en) * 1983-07-05 1990-02-20 The University Of Rochester Immunogenic conjugates
CA1338705C (en) * 1981-10-22 1996-11-12 Roy Curtiss Iii Vaccines obtained from antigenic gene products of recombinant genes
JPS58502181A (ja) * 1982-01-18 1983-12-22 サンド・アクチエンゲゼルシヤフト 新規プラスミドと細菌株並びにその製造法
JPS58146596A (ja) * 1982-02-25 1983-09-01 Takeda Chem Ind Ltd 組換えdna、それで形質転換させた微生物およびそれらの用途
GB8314645D0 (en) * 1983-05-26 1983-06-29 Wellcome Found Bivalent vaccines
US4761283A (en) * 1983-07-05 1988-08-02 The University Of Rochester Immunogenic conjugates
NZ209308A (en) * 1983-08-30 1991-08-27 Genentech Inc Vaccine against hsv involving a truncated membrane-free derivative of a membrane-bound protein
WO1985003521A1 (en) * 1984-02-01 1985-08-15 Enterovax Research Pty. Ltd. Bacterial strains
AU619908B2 (en) * 1984-02-01 1992-02-06 Enterovax Research Pty. Ltd. Bacterial strains
DK219084D0 (da) * 1984-05-02 1984-05-02 Frederik Carl Peter Lindberg Antigen
CA1340372C (en) * 1984-07-09 1999-02-02 John D. Clements Production of e. coli lt-b enterotoxin subunit
US4808700A (en) * 1984-07-09 1989-02-28 Praxis Biologics, Inc. Immunogenic conjugates of non-toxic E. coli LT-B enterotoxin subunit and capsular polymers
US5308835A (en) * 1984-07-09 1994-05-03 Praxis Biologics, Inc. Production of the E. coli LT-B enterotoxin subunit
ES8705033A1 (es) * 1984-12-04 1987-04-16 Biotech Australia Pty Ltd Un metodo para preparar una vacuna para uso en el tratamiento prevencion de diarrea porcina neonatol.
DK41885A (da) * 1985-01-31 1986-11-13 Slagteriernes Forskningsinst 987p-fimbrie-producerende mikroorganisme, vaccine til immunisering af grise samt fremgangsmaade til fremstilling af vaccinen
JP2660511B2 (ja) * 1985-05-15 1997-10-08 バイオテクノロジ−・オ−ストラリア・ピ−テイ−ワイ・リミテツド 経口ワクチン
IL78775A (en) * 1985-05-15 1992-06-21 Biotech Australia Pty Ltd Oral vaccines
US6103243A (en) * 1985-05-15 2000-08-15 Biotechnology Australia Pty, Ltd Oral vaccines
EP0264150B1 (fr) * 1986-10-13 1993-01-07 Solvay Microorganismes comportant des pili comme protéines porteuses, pili isolés à partir de ces microorganismes, procédé d'excrétion de peptides ou de protéines à l'aide de ces pili et utilisation de ceux-ci
FR2605017B1 (fr) * 1986-10-13 1989-10-06 Solvay Microorganismes comportant des pili comme proteines porteuses, pili isoles a partir de ces microorganismes et procede d'excretion de peptides ou de proteines a l'aide de ces pili.
DE3712890A1 (de) * 1987-04-15 1988-10-27 Teichmann Reinhard K Priv Doz Verwendung antigener substanzen zur prophylaxe oder therapie von stoerungen und krankheiten im verdauungstrakt von tieren und menschen
US5162226A (en) * 1987-08-24 1992-11-10 University Of Tennessee Research Corp. (U.T.R.C.) Therapeutic compositions against streptococcal infections, transformed hosts, methods of immunization and genetically engineered products
US5124153A (en) * 1987-08-24 1992-06-23 University Of Tennessee Research Corp. Therapeutic compositions against streptococcal infections, transformed hosts, methods of immunization and genetically engineered products
DE3871489D1 (de) * 1987-10-26 1992-07-02 Akzo Nv Impfstoff gegen e.coli-blutvergiftung bei gefluegel.
US5079165A (en) * 1988-06-29 1992-01-07 Praxis Biologics, Inc. Production of the E. coli LT-B enterotoxin subunit in S. typhi
CA1339307C (en) * 1988-09-06 1997-08-19 Roy Curtiss, Iii Oral immunization by transgenic plants
AU2793797A (en) * 1997-05-21 1998-12-11 Dae Woong Pharmaceutical Co., Ltd. A recombinant microorganism expressing an antigenic protein, adhesin
HU221664B1 (hu) * 1999-03-31 2002-12-28 MTA Állatorvostudományi Kutatóintézete Élő, szájon át adható Escherichia coli vakcina készítésére alkalmas törzs a sertések választási hasmenésének megelőzésére és a törzs előállítására alkalmas eljárás
JP2006506991A (ja) 2002-11-25 2006-03-02 デン・コンゲリエ・ヴェテリネー−オ・ランボホイスコレ ブタ多型およびその検出のための方法
HUE024565T2 (hu) 2004-02-03 2016-02-29 Prevtec Microbia Inc Élõ baktériumok alkalmazása növekedésserkentésre állatokban
WO2009004002A1 (en) * 2007-07-02 2009-01-08 Sbl Vaccin Ab Hybrid operon for expression of colonization factor (cf) antigens of enterotoxigenic escherichia coli

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL294835A (da) * 1962-07-19 1900-01-01
US3907987A (en) * 1972-05-25 1975-09-23 Canadian Patents Dev Enteric disease vaccine
GB1472624A (en) * 1974-09-02 1977-05-04 Canadian Patents Dev Enteric disease vaccine
US4237224A (en) * 1974-11-04 1980-12-02 Board Of Trustees Of The Leland Stanford Jr. University Process for producing biologically functional molecular chimeras
DE2530275A1 (de) * 1975-07-07 1977-01-27 Max Planck Gesellschaft Salmonella-coli-hybride, verfahren zu deren herstellung und vermehrung und apathogener lebend-impfstoff gegen salmonellosen
NO158880C (no) * 1977-11-08 1988-11-09 Genentech Inc Fremgangsmaate for fremstilling av et spesifikt pattedyrhormon.
FR2442271A1 (fr) * 1978-11-27 1980-06-20 Pasteur Institut Vecteur permettant l'insertion d'un gene procaryote ou eucaryote, et l'excretion de la proteine exprimee
US4337314A (en) * 1979-05-23 1982-06-29 Research Corporation Genetically attenuated bacterial vaccines with multiple mutations of the same phenotype

Also Published As

Publication number Publication date
EP0060129B1 (en) 1989-11-15
AU8331082A (en) 1982-09-28
ATE47961T1 (de) 1989-12-15
CA1201076A (en) 1986-02-25
DK172670B1 (da) 1999-05-10
JPS57171926A (en) 1982-10-22
JP2554611B2 (ja) 1996-11-13
WO1982003088A1 (en) 1982-09-16
AU559550B2 (en) 1987-03-12
NZ199866A (en) 1984-11-09
EP0060129A2 (en) 1982-09-15
DE3280019D1 (en) 1989-12-21
EP0060129A3 (en) 1983-06-01

Similar Documents

Publication Publication Date Title
DK101982A (da) Fremgangsmaade til fremstilling af en vaccine til hindring af gastroenterisk sygdom fremkaldt i et pattedyr af en patogen mikroorganisme
Wiktor et al. Cultivation of rabies virus in human diploid cell strain WI-38
DK0400958T3 (da) Levende vacciner
FI860015L (fi) Menetelmä rokotteen valmistamiseksi piluksia kantavien nisäkkään kudoksiin tarttuvien bakteerien aiheuttamia tauteja vastaan
Harrop et al. Protein synthesis and release by cultured schistosomula of Schistosoma mansoni
ES8203226A1 (es) Procedimiento de preparar complejos vacunantes por reaccion de arn ribonosales y de antigenos especificos.
FR07C0071I2 (fr) Culture de lawsonia intracellularis, vaccins anti-lawsonia intracellularis et agents de diagnostic
MX9203458A (es) Segmentos inmunogenicos que contienen glicoproteinas quimericas de las glicoproteinas de virus sincitial respiratorio humano.
ES462588A1 (es) Procedimiento para la obtencion de vacunas, por tratamiento de microorganismos en un campo electrico de corriente alter-na.
DK0749321T3 (da) Aktiv immunisering under anvendelse af et sideroforreceptorprotein
DK0524205T3 (da) Levende vacciner
Charlton et al. Skunk rabies
BR8807376A (pt) Microorganismo atenuado,composicao farmaceutica e processo de produzir um microorganismo atenuado
SE7610708L (sv) Forfarande for framstellning av ett antigent preparat
EP0259324A4 (en) Mastitis vaccine.
GB1413614A (en) Virus production
von Zeipel et al. Growth of viruses of the Russian spring-summer louping-ill group in tissue culture
Lásaro et al. Combined vaccine regimen based on parenteral priming with a DNA vaccine and administration of an oral booster consisting of a recombinant Salmonella enterica serovar Typhimurium vaccine strain for immunization against infection with human-derived enterotoxigenic Escherichia coli strains
Yanagawa et al. Conversion of serotype in Leptospira from hebdomadis to kremastos
DE3582422D1 (de) Biologische zubereitungen.
JPS56131385A (en) Cultivation of virus of hydrophobia
Larson A serum protection test in tularemic infections in white rats
KR850700110A (ko) 백신 및 이의 제조방법
Mitchell et al. Antibody Production in Milk Serum After Virus Instillation of Goat Mammary Gland VI.“Sham Infection” with Special Reference to Rabies
Wiblin , JL Melnick (Ed.) Progress in Medical Microbiology, Vol. 31, S. Karger (1985)

Legal Events

Date Code Title Description
B1 Patent granted (law 1993)
PUP Patent expired